ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
99.12%
Change (1 year)
Categories
Operating Margin for ADMA Biologics (ADMA)
Operating Margin as of May 2024 (TTM): -30.26%
According to ADMA Biologics 's latest financial reports and stock price the company's current Operating Margin is -30.26%. At the end of 2021 the company had an Operating Margin of -88.52%.
Operating Margin history for ADMA Biologics from 2012 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -88.52% | -50.66% |
| 2020 | -179.41% | 9.07% |
| 2019 | -164.50% | -57.5% |
| 2018 | -387.06% | 101.32% |
| 2017 | -192.26% | 5.03% |
| 2016 | -183.05% | -26.88% |
| 2015 | -250.36% | -14.71% |
| 2014 | -293.55% | -42.01% |
| 2013 | -506.17% | -28.53% |
| 2012 | -708.24% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | 27.34% | -190.35% | 🇺🇸 USA |
 Novavax NVAX | -149.57% | 394.28% | 🇺🇸 USA |
 Cel-Sci
CVM | -5,975.84% | 19,648.31% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.